A high percentage of tumour samples were found to be positive for CD133 in gastric (47–55%), pancreatic (55–68%), and cholangiocarcinomas (67%, biliary type of liver cancer) (Table 1) with the percentages reported based on the analysis using the two MAbs. The gene discussed is PROM1; the disease is liver cancer.